F-1/A: Empro Group Inc. Files for $5 Million IPO on Nasdaq Capital Market

Empro Group Inc., a Cayman Islands-based company specializing in beauty and healthcare products, has filed for an initial public offering aiming to raise $5 million on the Nasdaq Capital Market.

Summary

• Empro Group Inc., a Cayman Islands-based holding company, is seeking to raise $5 million through an IPO on the Nasdaq Capital Market.
• The company's business is primarily conducted through its Malaysian subsidiary, EMP Solution Sdn. Bhd., which has been operating since 2005.
• Empro Group distributes healthcare and beauty products, including its proprietary triangular eyebrow pencils and surgical face masks with Aerofit technology.
• The company's products are sold through its own retail outlets, major retailers like Watsons and Sasa, and online platforms such as Shopee and Lazada.
• For the fiscal year ended December 31, 2023, Empro Group's total revenue was approximately $3.70 million, with a net loss of about $0.32 million.
• The company experienced a significant decrease in healthcare revenue in 2023 due to reduced demand for medical masks and COVID-19 test kits.
• For the six months ended June 30, 2024, total revenue was approximately $1.70 million, with a net loss of about $0.28 million.
• The company plans to use the IPO proceeds for working capital, market penetration, development, operating expenses, and transaction expenses.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company has a strong history and is expanding into new markets, the recent financial performance shows a significant decline in revenue and profitability. The company's reliance on a limited number of suppliers and the potential for intellectual property issues also pose risks. The sentiment is neutral, with both positive and negative factors to consider.

Positives

• Empro Group has a 19-year brand history in the beauty and healthcare industry.
• The company has a track record of delivering safe and innovative products.
• Empro Group has received numerous awards for its contributions to the beauty and healthcare industry.
• The company has established strong relationships with partners, regulators, and government agencies.
• Empro Group has a robust and experienced management team.
• The company is expanding its product offerings with new brands like Premio and Mios.
• Empro Group has a comprehensive approach to marketing and distribution, including both online and physical stores.

Negatives

• Empro Group experienced a net loss of approximately $0.32 million in 2023.
• The company's total revenue decreased by 65.84% in 2023 compared to 2022.
• The company's healthcare revenue decreased by 68.56% in 2023.
• Empro Group experienced a net loss of approximately $0.28 million for the six months ended June 30, 2024.
• The company relies on a limited number of ODM/OEM and packaging supply partners.
• The company is subject to complex and evolving product safety laws, regulations and standards.

Risks

• The company operates in a dynamic and competitive healthcare and beauty industry with a limited operating history.
• The company's success depends on the continued popularity of its products and its ability to adapt to changing trends.
• The company's revenue decreased significantly in 2023 due to a reduction in COVID-19 cases.
• New product introductions may not be as successful as anticipated.
• The company relies on third-party e-commerce platforms and logistics providers.
• The company is subject to supply shortages, interruptions, and price fluctuations for raw materials.
• The company may be subject to intellectual property infringement claims.
• The company is controlled by a single shareholder, whose interests may differ from other shareholders.
• The company is a foreign private issuer and is exempt from certain Nasdaq corporate governance standards.
• The company may be classified as a passive foreign investment company, which could have adverse tax consequences for U.S. taxpayers.

Future Outlook

The company plans to expand its product offerings, enter new markets in ASEAN and Europe, and invest in new technologies.

Management Comments

• Under the leadership of our founder, Yeoh Chee Wei, our company has steadily and successfully transcended its humble origins in the beauty industry during an operating history that spans nearly two decades.
• Our accomplishments reflect a commitment to providing safe, professional-grade products of uncompromising quality.
• We take pride in our ability to adapt and respond swiftly to dynamic market needs, positioning our company as a versatile and forward-thinking enterprise.
• We believe that this multifaceted strategic synergy will remain pivotal in securing sustained success and a prominent industry position as we navigate into the future.

Industry Context

The beauty market is experiencing significant growth globally and in the Asia-Pacific region, while the PPE market is also expanding, creating opportunities for Empro Group's diversified product offerings.

Comparison to Industry Standards

• The beauty market is projected to reach $580 billion by 2027, with a CAGR of approximately 6%, according to McKinsey's The State of Fashion: Beauty 2023 report.
• The PPE market is expected to reach $113 billion by 2029, with a CAGR of 6%, according to Barnes Reports: 2023.
• In Malaysia, the beauty and personal care market is forecasted to generate $3.15 billion in revenue in 2023, with a projected CAGR of 2.59%, according to Statista.
• The PPE market in Malaysia is valued at $481 million in 2023 and is anticipated to grow at a CAGR of 7% from 2023 to 2029, according to Barnes Reports: 2023.
• The company's revenue decline in 2023 is consistent with the broader trend of reduced demand for COVID-19 related products as the pandemic subsides.
• The company's focus on expanding its cosmetics and skincare segment aligns with the industry trend of increasing consumer interest in these products.

Related Party Transactions

• The company has significant transactions with Jingga Anggun Sdn Bhd, a supplier of medical face masks, where the sole director is the son of the company's CEO and a related party.
• The company has significant transactions with Mosfac Sdn Bhd, a manufacturer of cosmetics and skincare products, where the company's CEO is a 50% shareholder and a director.
• The company has outstanding receivables from Mimo Motor Sdn Bhd, where the company's CEO is the sole shareholder and a director.
• The company has outstanding receivables from Emptech Upcycle Sdn Bhd, where the company's CEO is the sole shareholder and a director.

Stakeholder Impact

• Shareholders will be subject to dilution from the issuance of new shares in the IPO.
• Shareholders may face difficulties in protecting their interests due to the company's incorporation under Cayman Islands law.
• Employees may benefit from the company's growth and expansion.
• Customers may benefit from the company's new product offerings and expanded distribution channels.
• Suppliers may benefit from the company's increased production and sales.
• Creditors may be exposed to increased risk due to the company's debt obligations.

Next Steps

• The company plans to expand its product offerings and develop new products.
• The company plans to expand into new markets and territories within ASEAN and Europe.
• The company plans to invest in new technologies.

Key Dates

Keywords

IPO, beauty products, healthcare products, eyebrow pencils, face masks, skincare, Nasdaq, ASEAN, cosmetics, medical devices